Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06525259 · ClinicalTrials.gov registry record
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
A clinical trial of Diabetes Mellitus Type 2, Childhood-Onset, sponsored by George Washington University.
- Recruiting
- Registry status
- 3,600
- Enrollment target
- 20
- Study locations
NCT06525259 is a study of Diabetes Mellitus Type 2, Childhood-Onset that is actively recruiting participants, run by George Washington University. The registered enrollment target is 3,600 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT06525259, a study of Diabetes Mellitus Type 2, Childhood-Onset, is actively recruiting participants, sponsored by George Washington University.
- RECRUITING
- Registry status
- 3,600 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.
Conditions Studied
Study Locations (20)
New York
- NYU Langone Health- Brooklyn - Brooklyn
- NYU Langone Health- Long Island - Garden City
- NYU Langone Health- Manhattan - New York
- Albert Einstein College of Medicine - The Bronx
Arizona
- Arizona State University - Phoenix
- Phoenix Children's - Phoenix
North Carolina
- Atrium Health - Charlotte
- Wake Forest University - Winston-Salem
Ohio
- Cincinnati Children's Hospital - Cincinnati
- Nationwide Children's Hospital - Columbus
Alabama
- University of Alabama at Birmingham - Birmingham
California
- Children's Hospital Los Angeles - Los Angeles
Colorado
- Children's Hospital Colorado - Aurora
Florida
- Johns Hopkins All Children's Hospital - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,600 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2028-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06525259
The ClinicalTrials.gov registry entry for NCT06525259 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus Type 2, Childhood-Onset appearing as the primary indexed condition, and to 0 interventions.
NCT06525259 reports 20 study locations spanning 14 distinct geographic areas - top geographies include New York, Arizona, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06525259 about?
NCT06525259 is a clinical study titled "DISCOVERY of Risk Factors for Type 2 Diabetes in Youth". The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.
What is the current status of trial NCT06525259?
This trial is currently recruiting. The enrollment target is 3,600 participants. The study started on 2024-10-01. Estimated completion is 2028-01-31.
What conditions does trial NCT06525259 study?
This clinical trial studies the following conditions: Diabetes Mellitus Type 2, Childhood-Onset.
Who is sponsoring clinical trial NCT06525259?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06525259 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.